The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients
Article in Microbial Pathogenesis (November 2021)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients
Article in International Journal of Clinical Pharmacy (July 2020)
The outlook for precision medicine for the treatment of chronic hepatitis C infection: challenges and opportunities
Article in Expert Review of Precision Medicine and Drug Development (June 2020)